Jing Han , Ruiyun Wang , Lijuan Bai , Yun Liu , Man Liao , Liting Zhang , Lihua Liu , Benling Qi
{"title":"血清类胡萝卜素浓度与癌症幸存者全因死亡率的关系","authors":"Jing Han , Ruiyun Wang , Lijuan Bai , Yun Liu , Man Liao , Liting Zhang , Lihua Liu , Benling Qi","doi":"10.1016/j.clnesp.2025.08.014","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Cancer is the second leading cause of mortality in the United States, surpassed only by cardiovascular disease. As of January 1, 2019, approximately 16.9 million Americans were living with a history of cancer. Current evidence regarding the effect of serum carotenoids on all-cause mortality in cancer populations is limited. This study aims to investigate the association between serum carotenoid concentrations and survival among cancer survivors in the United States.</div></div><div><h3>Methods</h3><div>This prospective study examines the association between serum concentrations of five major carotenoids (α-carotene, β-carotene, β-cryptoxanthin, lycopene, lutein/zeaxanthin) and all-cause mortality risk among cancer survivors in a nationally representative cohort. Data were obtained from the National Health and Nutrition Examination Survey (NHANES) III and Continuous NHANES (2001–2006). Multivariable Cox proportional hazards regression models assessed the relationship between carotenoid levels and all-cause mortality outcomes, adjusting for relevant confounders. Restricted cubic spline (RCS) analyses were performed to determine the association between carotenoid concentrations and outcomes.</div></div><div><h3>Results</h3><div>During a mean follow-up of 15.2 years, 1089 deaths were recorded. In adjusted models, elevated serum concentrations of α-carotene, β-carotene, lycopene, and lutein/zeaxanthin were significantly associated with reduced risk of all-cause mortality (P trends <0.05). In contrast, β-cryptoxanthin showed no significant association. RCS plots revealed L-shaped associations for α-carotene, β-carotene, and lycopene, and U-shaped associations for lutein/zeaxanthin and β-cryptoxanthin.</div></div><div><h3>Conclusions</h3><div>Elevated serum α-carotene, β-carotene, lycopene, and lutein/zeaxanthin levels are associated with lower all-cause mortality in cancer survivors. These findings suggest that serum carotenoids could serve as important biomarkers for assessing long-term mortality risk and may inform dietary recommendations for cancer survivors.</div></div>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"70 ","pages":"Pages 165-173"},"PeriodicalIF":2.6000,"publicationDate":"2025-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Associations of serum carotenoid concentrations with all-cause mortality in cancer survivors\",\"authors\":\"Jing Han , Ruiyun Wang , Lijuan Bai , Yun Liu , Man Liao , Liting Zhang , Lihua Liu , Benling Qi\",\"doi\":\"10.1016/j.clnesp.2025.08.014\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Cancer is the second leading cause of mortality in the United States, surpassed only by cardiovascular disease. As of January 1, 2019, approximately 16.9 million Americans were living with a history of cancer. Current evidence regarding the effect of serum carotenoids on all-cause mortality in cancer populations is limited. This study aims to investigate the association between serum carotenoid concentrations and survival among cancer survivors in the United States.</div></div><div><h3>Methods</h3><div>This prospective study examines the association between serum concentrations of five major carotenoids (α-carotene, β-carotene, β-cryptoxanthin, lycopene, lutein/zeaxanthin) and all-cause mortality risk among cancer survivors in a nationally representative cohort. Data were obtained from the National Health and Nutrition Examination Survey (NHANES) III and Continuous NHANES (2001–2006). Multivariable Cox proportional hazards regression models assessed the relationship between carotenoid levels and all-cause mortality outcomes, adjusting for relevant confounders. Restricted cubic spline (RCS) analyses were performed to determine the association between carotenoid concentrations and outcomes.</div></div><div><h3>Results</h3><div>During a mean follow-up of 15.2 years, 1089 deaths were recorded. In adjusted models, elevated serum concentrations of α-carotene, β-carotene, lycopene, and lutein/zeaxanthin were significantly associated with reduced risk of all-cause mortality (P trends <0.05). In contrast, β-cryptoxanthin showed no significant association. RCS plots revealed L-shaped associations for α-carotene, β-carotene, and lycopene, and U-shaped associations for lutein/zeaxanthin and β-cryptoxanthin.</div></div><div><h3>Conclusions</h3><div>Elevated serum α-carotene, β-carotene, lycopene, and lutein/zeaxanthin levels are associated with lower all-cause mortality in cancer survivors. These findings suggest that serum carotenoids could serve as important biomarkers for assessing long-term mortality risk and may inform dietary recommendations for cancer survivors.</div></div>\",\"PeriodicalId\":10352,\"journal\":{\"name\":\"Clinical nutrition ESPEN\",\"volume\":\"70 \",\"pages\":\"Pages 165-173\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2025-08-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical nutrition ESPEN\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2405457725029006\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"NUTRITION & DIETETICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical nutrition ESPEN","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2405457725029006","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"NUTRITION & DIETETICS","Score":null,"Total":0}
Associations of serum carotenoid concentrations with all-cause mortality in cancer survivors
Background
Cancer is the second leading cause of mortality in the United States, surpassed only by cardiovascular disease. As of January 1, 2019, approximately 16.9 million Americans were living with a history of cancer. Current evidence regarding the effect of serum carotenoids on all-cause mortality in cancer populations is limited. This study aims to investigate the association between serum carotenoid concentrations and survival among cancer survivors in the United States.
Methods
This prospective study examines the association between serum concentrations of five major carotenoids (α-carotene, β-carotene, β-cryptoxanthin, lycopene, lutein/zeaxanthin) and all-cause mortality risk among cancer survivors in a nationally representative cohort. Data were obtained from the National Health and Nutrition Examination Survey (NHANES) III and Continuous NHANES (2001–2006). Multivariable Cox proportional hazards regression models assessed the relationship between carotenoid levels and all-cause mortality outcomes, adjusting for relevant confounders. Restricted cubic spline (RCS) analyses were performed to determine the association between carotenoid concentrations and outcomes.
Results
During a mean follow-up of 15.2 years, 1089 deaths were recorded. In adjusted models, elevated serum concentrations of α-carotene, β-carotene, lycopene, and lutein/zeaxanthin were significantly associated with reduced risk of all-cause mortality (P trends <0.05). In contrast, β-cryptoxanthin showed no significant association. RCS plots revealed L-shaped associations for α-carotene, β-carotene, and lycopene, and U-shaped associations for lutein/zeaxanthin and β-cryptoxanthin.
Conclusions
Elevated serum α-carotene, β-carotene, lycopene, and lutein/zeaxanthin levels are associated with lower all-cause mortality in cancer survivors. These findings suggest that serum carotenoids could serve as important biomarkers for assessing long-term mortality risk and may inform dietary recommendations for cancer survivors.
期刊介绍:
Clinical Nutrition ESPEN is an electronic-only journal and is an official publication of the European Society for Clinical Nutrition and Metabolism (ESPEN). Nutrition and nutritional care have gained wide clinical and scientific interest during the past decades. The increasing knowledge of metabolic disturbances and nutritional assessment in chronic and acute diseases has stimulated rapid advances in design, development and clinical application of nutritional support. The aims of ESPEN are to encourage the rapid diffusion of knowledge and its application in the field of clinical nutrition and metabolism. Published bimonthly, Clinical Nutrition ESPEN focuses on publishing articles on the relationship between nutrition and disease in the setting of basic science and clinical practice. Clinical Nutrition ESPEN is available to all members of ESPEN and to all subscribers of Clinical Nutrition.